https://www.taxtmi.com/caselaws?id=393201 The Court dismissed the appeal filed by the Revenue under Section 260A of the Income Tax Act, 1961 against the order of the Income Tax Appellate Tribunal. The Court rejected the questions raised by the Revenue concerning R&D expenditure and weighted deduction under section 35(2AB), emphasizing the importance of encouraging scientific research, particularly in clinical trials for pharmaceutical development. The Court concluded that the Tribunal's decision was sound, highlighting the need for a broad interpretation of scientific research for claiming deductions under the Act. en-us Tue, 25 Feb 2020 00:00:00 +0530 Mon, 08 Aug 2022 10:46:00 +0530 TaxTMI RSS Generator https://www.taxtmi.com/caselaws?id=393201 The Court dismissed the appeal filed by the Revenue under Section 260A of the Income Tax Act, 1961 against the order of the Income Tax Appellate Tribunal. The Court rejected the questions raised by the Revenue concerning R&D expenditure and weighted deduction under section 35(2AB), emphasizing the importance of encouraging scientific research, particularly in clinical trials for pharmaceutical development. The Court concluded that the Tribunal's decision was sound, highlighting the need for a broad interpretation of scientific research for claiming deductions under the Act. Case-Laws Income Tax Tue, 25 Feb 2020 00:00:00 +0530 https://www.taxtmi.com/caselaws?id=393201